Since 2014 the RCVS has trialled two different ADR services with the aim of helping resolve complaints between animal owners and veterinary practices that do not meet its threshold for serious professional misconduct.
Since October 2016, this has been in the form of the Veterinary Client Mediation Service (VCMS), administered by Nockolds Solicitors. The VCMS is free for both animal owners and veterinary professionals and cases will only be taken with the consent of both parties.
Eleanor Ferguson, RCVS Registrar, said: "We are very pleased that ADR in the form of mediation has received the unanimous support of RCVS Council members as part of the process for handling veterinary complaints.
"Throughout its trial period the VCMS has very much been complementary to our concerns investigation and disciplinary process. While we are bound by statute to investigate concerns, it has allowed our Professional Conduct Team to 'triage' cases, and to signpost complainants either to the College or the VCMS as appropriate. This has allowed greater time and resources to investigate concerns that could constitute serious professional misconduct.
"We also believe that the VCMS is good for both the public and the profession because it encourages both parties to communicate, find areas of agreement and come to constructive solutions, rather than being an adversarial process that assigns blame and adjudicates remedies."
Jennie Jones, a partner at Nockolds Solicitors which administers the VCMS, said: "The service is here to help veterinary clients and practices find a resolution for complaints that cannot be resolved within the practice. Complaints are referred to the VCMS by clients and practices where the relationship has become strained or communication may be difficult. Importantly the service does not look at who is right or wrong, but focuses on finding an outcome that both parties can live with and bringing an end to the complaint.
"In our experience this has ranged from reassuring clients and helping them to come to terms with what has happened, refunding fees, further explanations, apologies, small goodwill payments, securing procedural changes at the practice and agreement by the client to settle outstanding fees which have been withheld because of the complaint.
"We understand complaints are highly emotional and stressful for both parties, so the VCMS team will not ask parties to speak to one another directly. It is also not about assigning blame but is about moving forward to allow both parties to bring the complaint to a conclusion. When we hear from practices and clients alike that they can now sleep at night, or their relief that a complaint is resolved, I know ADR and the VCMS does help and make a difference."
The College says that during the trial period, 165 of the 870 enquiries received by the VCMS went to mediation. Of these, 129 were successfully mediated with the other 36 remaining unresolved. Of the other enquiries 297 resulted in the animal owner being referred back to the practice so that internal complaints processes could be exhausted first, 93 did not progress because the animal owner did not pursue the complaint, 73 were dealt with through advice, 66 did not progress as the practice declined to engage, 76 were outside the service’s remit and 100 are currently ongoing.
Taking into account the overall feedback received from both animal owners and veterinary professionals and the positive responses on the independence and fairness of the VCMS, Council agreed that Nockolds continue administering the scheme, with a review starting in 18 months’ time to take into account experience and learning as the scheme continues to evolve. During the Council meeting statements of support for the VCMS were also heard from a representative of the Veterinary Defence Society (VDS) and an independent consultant on consumer affairs.
A spokesperson for the VDS said: "The VDS assisted over 150 practices that agreed to participate in the ADR trial and developed a constructive working relationship with the VCMS staff. In the vast majority of cases mediation has resulted in a satisfactory outcome with little or no financial consequences.
"The Society considers this voluntary scheme particularly suited to the many client care complaints that are directed at the RCVS due to public misunderstanding of the College’s role, but the investigation of which creates disproportionate concern to the professionals involved. The independent nature of the VCMS has been a key feature of the trial, although access to experienced, non-judgemental, veterinary advice has provided the necessary professional expertise when necessary."
More information about the VCMS and its processes can be found on the service’s dedicated website: https://www.vetmediation.co.uk/
To contact the service directly call 0345 040 5834 or enquiries@vetmediation.co.uk
According to the FSA figures, 24.4% (758,263) of sheep and goats slaughtered between April and June this year had their throats cut without first being made insensible to pain, up from 15% in 2013, when the EU and UK-adopted legislation allowing an exemption for animals that are slaughtered for religious purposes came into force.
The number of chickens slaughtered without pre-stunning rose from 3% in 2013 to 18.5% (45,396,583) in 2017.
The BVA President Gudrun Ravetz said: "This huge increase in the number of sheep, goats and poultry that are not stunned or not stunned effectively before slaughter is a grave concern to our profession. Millions of individual animals are affected, making this a major animal welfare issue.
"The supply of meat from animals that have not been stunned massively outstrips the demand from the communities for which it is intended and is entering the mainstream market unlabelled.
"In the light of these official figures we reiterate our call for all animals to be stunned before slaughter. If slaughter without stunning is still to be permitted, any meat from this source must be clearly labelled and the supply of non-stun products should be matched with demand."
Welfare at slaughter is one of the UK’s most pressing health and welfare concerns for vets, according to the BVA’s latest member survey. The association has long campaigned for the re-introduction of law that guarantees all animals are stunned before slaughter on the grounds of animal welfare. While legislation exists to permit slaughter without pre-stunning, the BVA is calling for any meat or fish from this source to be clearly labelled to enable customers to understand the choice they are making when buying such products.
Photo: © Nevit Dilmen - Own work, Attribution-Share Alike 3.0 Unported
Dermipred is available in two pack sizes – 10mg and 20mg - to treat a range of dog sizes. Both presentations feature a four-way break tablet to enable accurate and flexible dosing, and the product is flavoured to aid compliance. The product is blister-packed for easy dispensing.
Ceva has produced an accompanying electronic brochure on CAD management options. It includes: understanding and decoding CAD, diagnosis and management of the condition.
Allison Henry, Dermipred product manager at Ceva said: "CAD affects approximately a million dogs in the UK, with 70% of all owners believing that the condition has had an impact on their dogs’ quality of life1.
"The addition of Dermipred to Ceva’s extensive dermatology range will provide veterinary professionals with even more treatment options for the management of pruritus and skin inflammation in CAD cases."
To support the launch of Dermipred, Ceva will be running an offer on its dermatology range of products: every client purchasing a box of each Dermipred presentation and a bottle of Modulis will receive one box of Dermipred 10mg, one bottle of the same Modulis size and one bottle of Douxo Calm shampoo and mousse free.
For further information, contact your local Ceva account manager or email cevauk@ceva.com.
Reference
HRH The Princess Royal has opened the Animal Health Trust's new cancer treatment and research facility in Suffolk.
The facility has been purpose-built to treat horses, dogs and cats with cancer. It will also assist in furthering understanding of the disease in animals.
Peter Webbon, Chief Executive of the AHT, said: "2012 marks 70 years of the AHT fighting disease and injury in animals, and the addition of the Cancer Centre is a landmark achievement in our history. We believe this is the first facility of its kind in Europe, purpose-built to treat horses, dogs and cats with cancer. We now have a short commissioning process to undertake but anticipate welcoming the first patients through the doors in early 2013."
The Kennel Club Cancer Centre at the AHT houses a linear accelerator (pictured right) and brachytherapy machine used in radiotherapy treatment, along with a 16-slice CT scanner to aid radiotherapy planning.
The new facility complements the AHT's existing cancer treatment options of surgery and chemotherapy meaning the Suffolk-based charity will be able to offer each and every patient the very best options for their specific case, whatever the diagnosis. With one in four dogs and one in six cats developing cancer at some time in their life the new centre will help many more animals fight cancer.
Peter Webbon, added: "It was thanks to a generous donation from the late Tom Scott, a long-term supporter of the AHT, that we were able to start this development. His donation, along with that from many other AHT supporters, and an interest-free loan of £1.5 million from the Kennel Club has meant this ambitious project has come to fruition so quickly."
It has taken just over a year to build the Cancer Centre which contains more than 2,600 tonnes of concrete and has eight-feet wide solid concrete walls.
On opening the facility, HRH The Princess Royal, President of the AHT, said: "This Cancer Centre is an exciting development at the AHT and will make a real difference for animals with cancer, here and now. It will improve the chances, for many animals, of beating this pernicious disease.
"Countless other horses, dogs and cats across the world with cancer, who will never be seen by an AHT clinician, will also benefit from knowledge gained from research in The Kennel Club Cancer Centre at the AHT."
The AHT has a strong history in cancer research and the Kennel Club Cancer Centre will enhance the charity's well established cancer research programme. Knowledge gained through the treatment of animals in the facility will contribute to the study of cancers, their causes, early diagnosis and treatment, and ultimately hopefully the prevention of some forms of the disease.
Steve Dean, Kennel Club Chairman, said: "I am very proud to be here today to celebrate the opening of the Kennel Club Cancer Centre. Thanks to the expertise available here at the Animal Health Trust, the Cancer Centre will provide advanced techniques for the diagnosis and treatment of cancer, to the benefit of many animals. It is exciting to consider how synergy between the Kennel Club Cancer Centre and the Kennel Club Genetics Centre can help to further the understanding of the inheritance factors that influence the development of cancer."
All bar one of the suspended drugs contain the NSAID flunixin. The other affected drug is the antibiotic, Tribrissen:
Allevinix 50 mg/ml Solution for Injection for Cattle, Pigs and Horses (Ceva Animal Health)
Cronyxin Injection, 5% w/v Solution for Injection, for cattle and horses (Cross Vetpharm Group Ltd)
Finadyne 50 mg/ml Solution for Injection for cattle, pigs and horses (Intervet UK Ltd)
Flunixin 50 mg/ml Solution for Injection for Cattle, Horses and Pigs (Norbrook Laboratories Limited)
Meflosyl 5% Solution for Injection for horses and cattle (Zoetis UK Limited)
Norixin 5% Solution for Injection for cattle and horses (Norbrook Laboratories Limited)
Pyroflam 50 mg/ml Solution for Injection for Cattle, Horses and Pigs (Norbrook Laboratories Limited)
Tribrissen 48% Suspension for Injection for horses, pigs and cattle (Intervet UK Ltd)
The British Equine Veterinary Association says that the decision to suspend the drugs was taken without consultation with the veterinary profession, and is urging the VMD to overturn the suspension in horses not destined for the human food chain, to reduce the potential impact on equine welfare.
Elanco Companion Animal Health has launched a competition to encourage veterinary professionals to showcase the company's new range of practice support materials for the company's parasiticides, Comfortis and Trifexin.
To enter the competition, you'll first need to order the support materials, which include: waiting room posters, client leaflets and a waiting room leaflet dispenser, modular window hangers, social media artwork and display kits which consist of 19 die-cut colour pieces for waiting room displays. Entry / order forms are available here.
Then create your display and email a digital photograph of it to Elanco before the 29th August 2014.
Matthew Rowe, Senior Brand Manager at Elanco said: "We're asking veterinary practices to use their creativity and imagination when putting up their parasite control displays. Last year's winner, the Animal Health Centre in Torquay, even composed their own song, so the more creative the better!"
The overall winner will win a team celebration worth £1000, and there are £250 Amazon vouchers for 11 regional winners.
For further information contact your local Elanco Companion Animal Health key account manager or email elancocahuk@elanco.com
For the study the RVC used VetCompass, its pioneering technology which analyses the veterinary records of 10 million animals from 1,000 veterinary practices in the UK and is now the world’s largest research database of anonymised clinical records.
The college says this made the study the largest-ever conducted into osteoarthritis in dogs under veterinary care – covering 455,557 dogs.
The study found that:
Rottweilers are the breed most prone to osteoarthritis, with the Old English Sheepdog and Dogue de Bordeaux also being very prone to the condition.
The large population of Labrador Retrievers in the UK makes them the most commonly treated breed for osteoarthritis in the UK.
2.5% of dogs involved in the study had osteoarthritis (which would equate to a total of around 200,000 dogs in the UK).
Dogs that were above average weight for their breed were nearly 2.3 times more likely to be diagnosed with the condition.
Males dogs were 1.2 times more likely to have osteoarthritis than female dogs.
The RVC says that on average, dogs receive their first diagnosis by the age of 10.5 years. Of the dogs who are diagnosed with osteoarthritis, 75% of cases are recommended to remain on medication as a form of pain relief.
It is hoped that this research will improve diagnosis times, which will enable dogs suffering from osteoarthritis to be treated faster.
Dr Dan O’Neill, RVC Senior Lecturer and co-author said: "Breed predisposition to disease is now recognised as one of the biggest problems facing dogs. Studies of huge populations, such as this one, are giving us vital insights into breed-related health problems in dogs that would have been impossible before VetCompass. This study has enabled us to positively support changes in dog welfare."
Anderson KL, O'Neill DG, Brodbelt DC, Church DB, Meeson RL, Sargan D, et al.: Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care. Scientific Reports 2018,8(1):5641.
Photo: Dog hip arthritis. Richard Meeson.
The initiative was the idea of one of the practice's client care co-ordinators, who suggested it whilst she was acting as the managing director for the day, as part of White Cross Vets' 80 year anniversary celebrations.
Managing director Tim Harrison said: "We believe we are the first veterinary practice in the UK to offer two full days paid peternity leave. Our ethos is all about caring for pets, and the first few days at home with a new addition are so special. It’s therefore essential that quality time can be dedicated to a new pet, in order to make sure they feel comfortable and safe in their new environment.
"As all of our team are all pet owners already, this time off will give them the chance to introduce and socialise any new family members with existing pets, which must be done carefully and under supervision.
"Bringing a new pet into the family takes a lot of patience and perseverance, and certain breeds or older pets can be harder to train or take longer to bond. Also there is a lot of preparation work that needs to be done in the home and garden when a young pet dog, cat or rabbit arrives, so this time off will hopefully make it easier for our team to give their new pets a safe and welcoming start in their new homes."
Other perks that White Cross Vets offers include five fully paid donation days a year to volunteer with chosen charities, a health care scheme, days off and cakes for birthdays, as well as subsidised Fitbits and gym memberships.
Davies says pulmonic stenosis is one of the most common congenital heart defects in dogs. In most cases it is caused by a malformation of the pulmonic valve with fusion of the leaflets (type A stenosis) or with the presence of rudimentary valves accompanied by hypoplasia of the annulus (type B stenosis).
Dogs with severe stenosis are at risk of sudden death, heart failure and have a decreased survival time in comparison to normal dogs.
Minimally invasive catheter based procedures (balloon valvuloplasty) have become the treatment of choice for valvular pulmonic stenosis, with good results in most but not all cases. French Bulldogs are predisposed to the condition and tend to not respond to valvuloplasty as well as other dogs.1
In this case, the dog was first referred to Pedro Oliveira, RCVS and European Veterinary Specialist in Small Animal Cardiology at Davies, for treatment of severe pulmonic stenosis.
An echocardiogram confirmed the presence of a type B stenosis accompanied by marked right ventricular hypertrophy and also an atrial septal defect.
A standard balloon valvuloplasty procedure was performed without complications and the dog initially showed improvement (click image right to enlarge). Soon after, however, she began to suffer episodes of weakness and collapse and was readmitted.
An echocardiogram showed that the right ventricular obstruction had worsened.
Pedro said: "Re-stenosis has been reported in up to 16% of cases following balloon valvuloplasty and in this case it was suspected to be due to the formation of scar tissue in the valve leaflets. The pressures inside the right side of the heart were now higher than left allowing blood to flow through the atrial septal defect from the right to the left atrium directly without receiving oxygen from the lungs.
"Whenever Gracie got excited or tried to exercise she would go 'blue' from lack of oxygen and collapse. In fact her quality of life was so poor that euthanasia was suggested at that point. For this reason we decided we should attempt this novel procedure. The only other option would have been open-chest surgery (patch graft) but this held a higher risk of complications during the anaesthesia and even death. Also, the cost of surgery would have been higher than this new option."
Pedro performed the procedure with fellow Davies cardiologist, Jose Matos, while Antonia Mavropoulou guided them using transoesophageal echocardiography.
Under a general anaesthetic the heart structure was assessed using transoesophageal echocardiography and angiography to choose the correct size of the stent for Gracie.
An 8mm wide and 4cm long stainless steel catheter tightly mounted on a balloon was chosen.
This was then positioned across the pulmonic valve and the balloon was expanded forcing the stent to open up to its full size (figure 2B). There was an immediate and significant improvement of blood flow through the stent (figure 2C), the patient recovered well and she was discharged four days later.
Re-examination after three months showed improved flow across the stent and a reversal of the right to left shunting across the atrial septal defect. Gracie stopped experiencing episodes of collapse or cyanosis and is now able to exercise and lead a more normal life.
Pedro said: "This technique has been used in very few cases in the whole world and to the best of our knowledge this is the first time it has been used in the UK.
"It is more technically challenging and costly than a standard ballooning although it may provide an effective, safe, and cheaper alternative to patch graft surgery. In this particular case we feel it made an important difference in terms of quality of life and prognosis for Gracie.
Complete Veterinary Care (CVC) is to launch the BooBooLoon, a new alternative to the Elizabethan collar at BSAVA Congress.
According to the company, the inflatable collar offers comfort and protection advantages over old style Elizabethan collars and other devices that restrict pets from harming surgical wounds and irritating skin disorders.
The BooBooLoon, which is made in the US by a manufacturer called Headroom, will be distributed by CVC to veterinary professionals and pet shops. The collar will be available in five sizes from extra small through to extra large.
Marcy Colangelo, President of Headroom invented the device when her boxer dog Mitzi had surgery for skin cancer. She said: "I just couldn't stand leaving that cone on her. It was like putting her head in a tunnel."
Inspired by her own travel pillow, she came up with the BooBooLoon.
Marcy added: "I know the entire CVC Group administrative and veterinarian management team are enthusiastic about their upcoming BooBooLoon inflatable pet recovery collar launch. The CVC Group is very experienced and is committed to providing excellent service and quality to the veterinary profession and to independent pet shops throughout the United Kingdom."
The Mayor of Loughton, Councillor Philip Abraham, officially opened the Vets4Pets Loughton veterinary surgery inside Pets at Home at the Epping Forest Shopping Park, before enjoying a guided tour of the bright and modern facility.
Cheryl, who stars in the BBC’s children’s TV show The Pet Factor, said: "It’s fantastic to be able to open the doors to Vets4Pets Loughton and reach a landmark number of practices for the group.
"The opening event gave us chance to meet new clients, and welcome them to the practice."
Cheryl qualified in 2009 and is also a joint venture partner at Vets4Pets Chadwell and Newbury Park in Ilford.
Nick, who qualified in 2008, is also joint venture partner at Newbury Park, Romford, Beckton and Dagenham.
Nick said: "I have always been interested in caring for pets and have several dogs and cats at home.
"I love being a veterinary nurse and I’m delighted to have another opportunity from Vets4Pets to open my fifth practice.
"Once again the process to open a practice has been easy and we’ve had brilliant support on all aspects from Vets4Pets.
"I’m now looking forward to welcoming pets and their owners to Vets4Pets Loughton and providing the highest standard of veterinary care to the area’s pets."
The new practice will create five new jobs, with two vets, veterinary nurse, two pet care assistants and a receptionist.
Chief executive of the Pets at Home Vet Group, Andrei Balta, said: "Cheryl and Nick are two great advocates for the veterinary profession and we’re delighted they are part of the group.
"Wherever we have opened, pet owners have responded enthusiastically to our state-of-the-art practices and convenient opening hours.
"The joint venture model we operate across our practices provides the support vets and vet nurses need to run their businesses.
"It allows them to focus on what they really love, looking after the health of animals, while the support team helps with other areas including marketing, HR and business strategy."
Esteban Gonzalez joins the practice in Southfields, Laindon, from Ars Veterinaria in Barcelona, one of the leading veterinary hospitals in Spain.
Esteban (pictured right with VRCC Clinical Director, Henry L’Eplattenier) graduated at the Autonomous University of Barcelona (UAB) in 2002. After working as a veterinary emergency in Paris for a year, he did an 18-month rotating internship of at the UAB. He then worked for three years in a veterinary hospital as a soft tissue and emergency surgeon.
In January 2009, he began a three-year residency in small animal surgery in Neuilly-sur-Seine, France, under the supervision of Dr Jean-Francois Bardet, one of France’s leading veterinary surgeons.
As part of his training, he made several visits to the US with graduates of American surgery, as well as specialists in oncology, anaesthesia and emergency medicine.
During his residency he published several articles and gave presentations at national and international conferences.
Esteban graduated as a European specialist in surgery and a diplomate of the European College of Veterinary Surgeons (ECVS) in February 2014. He then worked as a specialist surgeon in the UK for two years until last year when he joined Ars Veterinaria.
VRCC says his is the first of a number of planned appointments which will result in two veterinary surgeons appointed to each of the practice’s eight specialities.
The business is also undergoing a rebranding and rebuilding operation that will see the practice renamed as Southfields.
Operations manager Daniel Hogan said: "The recruitment plan will ensure we continue to offer state-of-the-art veterinary medicine across the board — in oncology, soft tissue surgery, orthopaedics, internal medicine, feline medicine, anaesthesia, diagnostic imaging, neurology and cardiology."
Clinical director at VRCC Henry L’Eplattenier said: "Esteban is a hugely experienced and well-respected specialist, who we are delighted has chosen to join the team here.
"Having his kind of expertise adds to our already considerable skill-sets and is part of a major drive to attract some of the best people in the industry to VRCC."
For more information, visit www.vrcc.co.uk.
York-based Alstoe Animal Health, maker of Gleptosil and Vetergesic, has been acquired by French company Sogeval, a leading supplier of companion and livestock animal products.
Established in 1994, Alstoe was privatelv owned by the two original partners, John Nellis and lan Ryder.
For the last five years the company has been working with Sogeval to develop flavoured tablet pharmaceutical brands from Sogeval whilst the two companies have collaborated to make Vetergesic successful in France.
The business will continue to trade from the current premises for the foreseeable future and says it will maintain its high standard of customer service and product supply.
John Nellis said: "lt will be business as usual. We look forward to continued sales growth for our existing brands and the introduction of exciting new products in the future".
Dr. lan Ryder said: "Our companies have worked very well together in the past. The acquisition will bring fresh impetus to the business and ensure continued growth"
The current Alstoe team remains in place to assist with any enquiries. For further information contact info@alstoe.co.uk or telephone: 01347 878605
The Blue Cross is calling for nominations from veterinary practices across the country for its Veterinary Nurse of the Year Award 2009.
The annual award is presented at the British Veterinary Nursing Association (BVNA) Annual Congress. It recognises the contribution of veterinary nurses in educating the public about responsible pet ownership and the welfare of pets in the community. This year's Congress will take place on 9-11 October at the Kettering Conference Centre, Northamptonshire.
Last year's award was won by Rebecca Darbyshire for her outstanding contribution to animal welfare, both within her veterinary practice and among the local community in Pocklington, York.
Rebecca Darbyshire was nominated by vet and colleague Matt Brash at Battlefields veterinary clinic in Pocklington.
Mr Brash said: "Rebecca is an outstanding, unassuming professional nurse. She runs all of the clinics that a modern day nurse does, but still has the time for anybody - whatever they need, whenever they need it. She has developed such a close relationship with our clients that they would often rather see her than a vet!"
Nominations for this year's award can be made by completing the nomination form on The Blue Cross website at: www.bluecross.org.uk/BVNA2009 or by contacting Sally Leathem on 01993 825577. The deadline for nominations is Friday 14 August 2009.
The Blue Cross has taken the lead in animal care for over a hundred years. Its four animal hospitals provide a lifeline for pet owners on low incomes. Its community vet services also cater for elderly and disabled people. Without the charity's hospitals, and the services they provide, many people would be without the benefits that pet ownership can bring.
Vetsonic has announced the launch of a tablet form of Arthriaid Omega.
Designed to support joint health, the nutraceutical product contains glucosamine, chondroitin, omega 3 fatty acids, MSM, manganese sulphate plus vitamins C and E.
This new tablet form joins the existing range of palatable liquids, chews, cat gel and the original ArthriAid tablets and ArthriAid HA powder, which will continue to be available.
CEVA Animal Health is launching a new TV advertising and marketing campaign to promote its veterinary behaviour products, DAP and Feliway, in the run up to this year's firework season.
The campaign will feature a new animated character 'Dap the Dog', who will join 'That Purple Cat' in educating pet owners on the behaviours expressed by pets that are fearful of loud noises during fireworks, and the benefits of using DAP and Feliway. The adverts will be aired throughout October on ITV2, E4, More4 and Channel 4 (London only) starting on Monday 4th October and will be seen by 11.5 million ABC1 women.
A range of firework marketing materials have been produced to support veterinary practices and help educate owners who have noise phobic pets. These include client leaflets, an A4 leaflet holder, waiting room display materials and a firework poster all featuring the characters from the advert. CEVA's petfireworkfear website - www.petfireworkfear.co.uk/ - has also been updated to include the new TV advert, downloadable versions of all materials and tips on how to prepare pets for fireworks. In addition, www.dapfordogs.com/ and www.feliway.com/ will feature a voucher offering pet owners a free 60ml spray when they purchase a DAP or Feliway diffuser from their local veterinary practice.
The support comes in light of recent research1, carried out by CEVA, that revealed 80% of pet owners have had a pet that has been afraid of fireworks, with more than half of dog owners wanting to ban them altogether because they are too upsetting for their animals.
Julia Wood, product manager at CEVA Animal Health, said: "Fireworks are the most stressful event that a pet can experience and, in most cases, owners have noticed their animals becoming visibly unsettled with 49% of dogs shaking1 and 65% of cats hiding1. The new TV advertising campaign and marketing support will educate pet owners on behaviours expressed by pets with a fear of loud noises and the importance of taking proactive action by using DAP and Feliway."
CEVA will be running its annual firework display competition amongst veterinary practices throughout October for the best decorated waiting room.
For further information on CEVA's firework campaign or its marketing support, please contact your local CEVA territory manager or call CEVA Animal Health on 01494 781510.
The Royal College of Veterinary Surgeons has won European funding to develop its innovative system for the online recording of veterinary nurse training.
The College has been granted Leonardo da Vinci funding to the tune of €245,000 to investigate how its Nursing Progress Log (NPL), used as part of the Level 3 Diploma in Veterinary Nursing in the UK, can be adapted for use on the continent.
Dubbed 'Veterinary European Clinical Training and Assessment Record' (VECTAR), the project will explore how best the recording tool, and the training of practice-based mentors for veterinary nurse students, can be developed in the six partner veterinary nursing schools - based in Norway, Finland, the Netherlands, Belgium, Portugal and Italy.
The project will be overseen by the Federation of European Companion Animal Veterinary Associations (FECAVA), which means that European veterinary employers will have a direct link to the project throughout.
This is the latest of several similar projects in which UK best practice in veterinary nursing has led EU developments, and it is timely that the funding was secured during the 50th anniversary of veterinary nurse training in the UK (www.rcvs.org.uk/VNat50).
Libby Earle, RCVS Head of Veterinary Nursing said: "We were delighted that the project has been granted funding, as it reinforces the position of UK veterinary nurse training as the gold standard in Europe. But there are still lots we can learn: the project will be a two-way process and we hope to gain from the experience of our European colleagues in developing and improving the NPL, and accessible training and support for those involved in coaching student VNs in practice."
The VCMS, which is administered by Nockolds Solicitors, was formally launched by the RCVS as an alternative dispute resolution service in October 2017 following a year-long trial.
The aim of the service is to resolve, by mediation, disputes between clients and veterinary practices that do not meet the threshold of serious professional misconduct that is needed for the RCVS to investigate a concern through its formal processes.
Since the service’s trial, which started in October 2016, the VCMS has given preliminary mediation advice on how to resolve a case in more than 1,700 instances with over 580 cases having gone to full mediation of which 89% have concluded with a resolution.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, said: "From the perspective of both the public and the profession, the establishment of the VCMS has been a "win-win" situation. For the public it has provided them with an additional route to solve those complaints which wouldn’t cross the threshold to progress in the concerns investigation process.
"For the profession it has provided a more appropriate format for resolving a client dispute that doesn’t involve the time, effort and formal process of an RCVS investigation for those cases that will never amount to serious professional misconduct. I think this has been demonstrated by the fact that the vast majority of the profession are willing to engage with the VCMS process, even though it is entirely voluntary.
"The VCMS has also had a positive impact on the College and its concerns investigation process, allowing us to focus greater resources on those cases that do meet our threshold of serious professional misconduct. This has had a very clear impact on the speed with which we either close cases or move them on to the next stage of consideration by the Preliminary Investigation Committee (PIC), which, again, is important to both the public and the profession."
The College says that around 90% of cases investigated at Stage 1 of the process are now either closed or referred to PIC within four months – the College’s key performance indicator at this stage. This compares to around 50% of these cases being closed or referred within four months at Stage 1 in 2016.
The College also says that in total (including both preliminary and full mediation cases), 86% of the cases dealt with by VCMS were successfully mediated and feedback from both clients and veterinary practices has been largely positive. In client feedback from the third quarter of 2018, 93% said they would use the VCMS again and 79% considered it to be fair, while the equivalent figure amongst veterinary practices was 94% and 87% respectively.
Jennie Jones, a partner at Nockolds Solicitors who heads up the VCMS, said: "It is a good sign that mediation is largely working as it should when both parties are reporting similar satisfaction rates and we pride ourselves on negotiating resolutions that are acceptable and beneficial for both the clients and the practices.
"It is great to see that our efforts are also having an impact on the RCVS concerns investigation system by allowing it to concentrate on more serious cases."
More information about the RCVS concerns investigation process, including the different stages of an investigation, can be found at www.rcvs.org.uk/concerns
Further information about the VCMS can be found on its website at www.vetmediation.co.uk or by calling 0345 040 5834.
Intervet/Schering-Plough Animal Health, makers of Caninsulin, is launching Pet Diabetes Month, a call to arms for owners to check if their pets might be at risk of diabetes. To enable the testing, urine glucose test strips will be made available free of charge to vet practices to dispense during Pet Diabetes Month (1 - 30 November 2009).
ISPAH says that despite general awareness of the signs of diabetes in humans, many pet owners still have little understanding of the condition in their animals. The urine-sampling aspect of the campaign, entitled the Great Pet 'Pee' Test, intends to address this by making test strips freely available. It is hoped that many of the undiagnosed diabetics in the UK's pet population will be identified during the campaign and appropriate treatment plans undertaken.
Practices wishing to participate in Pet Diabetes Month and the Great Pet 'Pee' Test will benefit from practice leaflets containing the test strips, waiting room posters, the website http://www.petdiabetesmonth.co.uk/ and the opportunity to be included in a regional PR campaign.
Shoumik Das BVM&S MRCVS, Marketing Manager for Caninsulin, said; "The tremendous success of National Vaccination Month clearly demonstrates that pet owners are keen to take an active interest in the care of their pet, but often don't know where to start. By providing the test strips free to practices to distribute to pet owners we are once again giving them the tools to take control of their pets' health. If we can identify even a few of the missing thousands of pets potentially at risk from diabetes, that has to be good news for the pets and also vet practices."
Interested practices should contact their local Intervet/Schering-Plough Territory Manager or phone the company's Veterinary Support Group on 01908 685685.
The BSAVA has released a statement in support of the television programme Pedigree Dogs Exposed - three years on, made by Jemima Harrison. The programme was broadcast earlier this week on BBC4 as a follow up to a documentary which was first shown in 2008.
BSAVA President Andrew Ash said: "Jemima Harrison has highlighted an important issue. It is essential that veterinary surgeons, dog breeders and the general public no longer accept that breeding for extremes of conformation or knowingly from animals with inherited disease is an acceptable practice. The programme highlighted two main areas of concern, firstly the small genetic pool that exists in many breeds and secondly continued breeding for extremes of body shape. Both these areas must be addressed urgently. A civilised nation must agree that it is not acceptable to breed dogs that cannot function as dogs."
He went on to say that: "BSAVA supports the health schemes that are now available to owners as steps in the right direction. However it is difficult to believe that health schemes are going to be sufficient in themselves to tackle these problems rapidly and effectively. It is particularly perverse to be promoting health schemes and yet continuing to allow the registration and showing of progeny with Coefficients of Inbreeding as high as 47.5% or where the animal concerned is known to have failed a screening test (significant in that breed)."
Vice President Mark Johnson said: "We are supportive of the changes that the Kennel Club has made so far, and applaud them in allowing the introduction of new genes into certain breeds as demonstrated by the registration of the LUA Dalmatian. I support the introduction of the "Mate Select" scheme (link) but believe that the Kennel Club should adopt the Advisory Council on Welfare in Dog Breeding recommendation and not register puppies with a coefficient of breeding (over 5 generations) greater than 12.5%."
The BSAVA says it supports the BVA in its call for a radical review of all breed standards to ensure that they actively protect the health and welfare of the dog. However it is important to remember that inherited disease is not just a problem of purebred dogs and BSAVA supports the introduction of legislation that seeks to improve the health and welfare of all dogs.
The BVNA has officially launched its new website along with refreshed branding.
The Association says the new site was designed to showcase the association’s key activities of CPD, member representation and support. User navigation has been improved, along with an increased focus on sharing the association’s news on campaigning and lobbying activities.
A President’s Blog will feature updates from association president Fiona Andrew, while non-members can sign up to receive the BVNA newsletter which will highlight both regional and national activities. In response to feedback from a consultation last year, the association has expanded its advice pages. Veterinary nurses can now find information on mental health support, the Members Advisory Service, peer to peer support and financial help that is available through the Daphne Shipman Benevolent Fund.
Fiona said: “2015 is a pretty momentous year for the veterinary nursing profession and I feel very honoured to be representing our members at this key time. We have campaigned for a long time on professional status for veterinary nurses and it is so gratifying to see this come to fruition with the new Royal Charter being introduced in our 50th Year. There’s still much to be done though, and we’re looking forward to sharing our aims and achievements for 2015 with members and the rest of the profession.”
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
References
Boehringer Ingelheim Vetmedica has increased its range of marketing and educational materials about heart disease and the use of Vetmedin.
The materials include canine heart disease awareness posters for either the waiting room or consult room which feature 'static cling' technology, enabling them to stick to any surface without adhesive, as well as information leaflets, owner booklets, health diaries and dog tags.
Materials for dog owners are designed to inform about the signs to look out for with heart disease, and the steps involved in the diagnosis and management of the condition. There's a post-prescription owner booklet which features a health diary for dog owners to fill in, allowing them to track any changes in their dog's condition, as well as details on the telltale signs of heart failure and the benefits of Vetmedin.
Also available in the range are materials to help make prescribing the optimum dose of Vetmedin as easy as possible, including dose optimisation mouse mats, dose dials, treatment algorithms and interactive dose calculators on CD for those veterinary practices without internet access.
For further information, please contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
Ceva Animal Health, maker of Milbactor, Vectra 3D and Vectra Felis, has launched a new booklet for practices to give clients: Protecting your Pet from Parasites.
The booklet offers an overview of the common ecto and endoparasites that can affect dogs and cats in the UK, including fleas, ticks, roundworm, tapeworm and lungworm. It explains how pets can become infested, how to tell if a pet is infected and the potential health problems that may result from an infestation. It also highlights the importance of routine treatment to help prevent infestation and transmission of diseases.
At the end of the booklet there is a check list designed to help pet owners and their vets determine the parasites that pose the greatest threat to their pet, taking into account factors such as whether there is more than one pet in the household, whether the pet scavenges or hunts wildlife or whether there are children in the household.
Rob McLintock MRCVS, companion animal business unit manager at Ceva Animal Health said: "Recent research1 carried out by Ceva demonstrated that pet owners are increasingly confused by what parasites are being treated by their current anti-parasitic regime. The new booklet will provide owners with a comprehensive overview of both ectoparasites and endoparasites and facilitate discussion between clients and their vets to assess the best treatments on a case by case basis."
Ceva has recently launched the Ceva Protection System for dogs, a simple two-step solution featuring Milbactor and Vectra 3D to provide comprehensive ectoparasite and endoparasite protection with one monthly topical treatment and one flavoured tablet. The Ceva Protection System also features Vectra Felis, offering fast-acting flea protection for cats, and Acclaim® for sustained treatment of the pet's home environment.
To request copies of the booklet, call Ceva Animal Health on 01494 781510 or contact your local Ceva Animal Health territory manager.
536 cat and dog owners, February 2015
The Feline Advisory Bureau (FAB) has changed its name to International Cat Care in order to better reflect the work the charity does to help improve the lives of cats both in the UK and internationally.
Along with the name change, the charity has developed a completely new visual identity, which has been applied to its new website (www.icatcare.org).
Claire Bessant, CEO of International Cat Care, said: "We continue to evolve as a charity and we are increasingly working internationally to help vets and local communities provide better care for cats. While our mission and core values will remain the same, we needed a strong brand identity to better reflect this work and to help us engage more directly with consumers and vets."
Underneath the International Cat Care umbrella, there are three core areas which are designed to help streamline the charity's work and make it easy for vets, professionals and consumers to engage in the right way. The three areas are:
The charity's new website will continue to host information and advice on virtually every aspect of cat care, but also showcases the charity's work internationally. Most recently, the team has been in Sudan teaching vets about the safe handling and neutering of cats, with a special emphasis on street cats.
Claire Bessant continued: "We really wanted to achieve a clear and succinct explanation of who we are and what we do, and we think the new name and visual identity perfectly sums this up. It's been such a rewarding process because the rebrand has been so positively received by our dedicated staff, members and supporters."
International Cat Care will be officially unveiled on the first day of this year's BSAVA Congress, where vets and the media will be invited to the stand to see the new identity for the first time, and for a glass of celebratory champagne.
To meet the team and find out more about the rebrand, visit stand 704 at the BSAVA Congress.